A Phase II Trial of Fludarabine/Melphalan 100 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Patients With Lymphoma-Reference-Cited by-同舟云学术

A Phase II Trial of Fludarabine/Melphalan 100 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Patients With Lymphoma

Published:2015-11 Issue:11 Volume:15 Page:655-663
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Lee Jung-Hee,Lee Je-Hwan^ORCID,Kim Dae-Young,Seol Miee,Lee Young-Shin,Kang Young-Ah,Jeon Mijin,Lee Kyoo-Hyung

Funder

Asan Institute for Life Sciences

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference27 articles.

1. Bone marrow transplantation in patients aged 45 years and older;Klingemann;Blood,1986

2. Outcome after allogeneic bone marrow transplant for leukemia in older adults;Ringden;JAMA,1993

3. Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen;Anderlini;Bone Marrow Transplant,2005

5. Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia;Sorror;J Clin Oncol,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Outcomes of Allogeneic Stem Cell Transplantation for Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma: Multi-center Experience from Turkey;Indian Journal of Hematology and Blood Transfusion;2024-07-26

2. Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil;Annals of Hematology;2022-10-05

3. Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma;Biology of Blood and Marrow Transplantation;2019-07

4. Fludarabine/Melphalan 100 mg/m2 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis;Biology of Blood and Marrow Transplantation;2019-06

5. Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factors;Leukemia & Lymphoma;2017-11-22